We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aevi Genomic Medicine Inc | NASDAQ:GNMX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.1659 | 0.1601 | 0.165 | 0 | 01:00:00 |
FORM 3
|
Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Expires: February 28, 2011 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person * River Charitable Remainder Unitrust f/b/o Isaac Blech |
2. Date of Event Requiring Statement (MM/DD/YYYY)
|
3. Issuer Name and Ticker or Trading Symbol MEDGENICS, INC. [MDGN] |
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
___
X
___ 10% Owner
_____ Officer (give title below) _____ Other (specify below) |
|
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned |
|||
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Common Stock Warrant | 9/22/2010 | 9/22/2015 | Common Stock | 230357 (2) | $9.13 (1) | D |
|
Explanation of Responses: | |
( 1) | The exercise price for these warrants is denominated in British Pounds Sterling. The stated exercise price is GBP 5.60. The dollar value set forth in Table II is based on the currency ratio of $1.63 to one British Pound Sterling as of April 7, 2011. |
( 2) | The number of shares underlying the Common Stock Warrant was incorrectly listed as 230,537, rather than 230,357, in the Form 3 previously filed due to a clerical error. This amendment also includes Isaac Blech as a reporting person. Mr. Blech is the trustee of River Charitable Remainder Unitrust (the "Trust") and, as such, has sole voting and dispositive power over the Trust. Mr. Blech disclaims beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein, if any. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
River Charitable Remainder Unitrust f/b/o Isaac Blech
75 ROCKEFELLER CENTER, 29TH FLOOR NEW YORK, NY 10019 |
|
X |
|
|
|
BLECH ISAAC
75 ROCKEFELLER PLAZA, 29TH FLOOR NEW YORK, NY 10019 |
|
X |
|
|
Signatures
|
||
/s/ Ori Solomon, Attorney-In-Fact for River Charitable Remainder Unitrust f/b/o Isaac Blech | 6/9/2011 | |
** Signature of Reporting Person | Date | |
/s/ Ori Solomon, Attorney-In-Fact for Isaac Blech | 6/9/2011 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Aevi Genomic Medicine Chart |
1 Month Aevi Genomic Medicine Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions